GILL JOHN
SEC Form 4 insider trading activity
GILL JOHN has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Apr 6, 2026.
On the most recent filing, GILL JOHN is listed as Director at Altimmune, Inc. Inside the rolling window, GILL JOHN reported 2 open-market purchases totaling $83K in ALT and no open-market sales. The largest disclosed transaction in the window is a purchase of 12,500 ALT shares on Dec 23, 2025, worth $51K.
Companies traded
Other insiders at ALT
Insider Buying
$83K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GILL JOHN made?
GILL JOHN has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does GILL JOHN trade?
GILL JOHN has filed SEC Form 4 disclosures for 1 company, including ALT.
When was GILL JOHN's most recent SEC Form 4 filing?
GILL JOHN's most recent SEC Form 4 filing on Tracefour is dated Apr 6, 2026.
What is GILL JOHN's total buy and sell value in the current window?
Inside the rolling retention window, GILL JOHN bought $83K and sold $0 based on SEC Form 4 filings.
What was GILL JOHN's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,500 ALT shares on 2025-12-23, worth $51K, per SEC Form 4 filings.